EpiCast Report: Osteoarthritis – Epidemiology Forecast to 2026

2017-09-04
Price :
Published : Sep-2017
No. of Pages : 50

EpiCast Report: Osteoarthritis – Epidemiology Forecast to 2026

Summary

Osteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the American College of Rheumatology (ACR), OA is the most common cause of disability in the elderly. The most commonly affected joints are the knee, hip, hand, and spine. It is characterized by breakdown of the cartilage, bony changes of the joints, deterioration of tendons and ligaments, and various degrees of inflammation of the joint lining.

To forecast the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies that provided these epidemiological data in the 7MM. GlobalData epidemiologists obtained data for the diagnosed prevalent cases (symptomatic) as well as data for the severity segmentation of the diagnosed prevalent cases (symptomatic) from primary market research. In addition, the forecast is supported by robust, country-specific data that was obtained from various authentic sources such as research articles published in peer-reviewed journals.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases (symptomatic) of hand OA will increase from 17,948,101 cases in 2016 to 20,413,591 cases in 2026 at an annual growth rate (AGR) of 1.37%, the diagnosed prevalent cases (symptomatic) of knee OA will increase from 15,235,201 cases in 2016 to 17,641,626 cases in 2026 at an AGR of 1.58%, and the diagnosed prevalent cases (symptomatic) of hip OA will increase from 3,361,141 cases in 2016 to 3,867,480 cases in 2026 at an AGR of 1.51%.

Scope

– The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors and global trends of hand OA, knee OA, and hip OA in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
– It includes a 10-year epidemiological forecast for the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA segmented by age (beginning at 18 years and older) and sex in these markets. The diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA are further segmented by severity using Kellgren-Lawrence (KL) grading into mild (KL = 2), and moderate to severe (KL = 3 to 4).
– The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
– The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global OA market.
– Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.
– Understand magnitude of OA population by disease severity.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Libbs Farmaceutica Ltda – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which offers biological drug products. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central nervous system transplant. It also offers active pharmaceutical ingredients, drugs and other medical products. Libbs Farmaceutica provides products in several dosage forms including injectable solutions, drops, tablets, capsules, coated tablets, powders, moisturizing fluids, gels and creams. The company carries its synthesis of active ingredients and manufacturing of medicines at its units located in Barra Funda and Embu das Artes, Sao Paulo. Libbs Farmaceutica is headquartered in Sao Paulo, Brazil. Libbs Farmaceut......
$250

PharmaCell BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PharmaCell BV (PharmaCell) is a contract manufacturing organization that offers services for cellular therapies and regenerative medicine. The organization manufactures commercial cell therapy products in the European markets. Its services include cell culture scale-up, manufacturing of advanced therapeutic medicinal products, process development, transfer of technologies and controlled temperature transportation. PharmaCell provides capacity reservation and patient treatment scheduling and shipper validation, among others. The organization offers its services in the areas of operations, technology transfer, process development and logistics. It manufactures clinical trial material in Phase I to Phase III clinical trials. PharmaCell is headquartered in Maastricht, the Netherland......
$250

Newcastle University – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri-business management, agriculture, ancient history, animal science, archaeology, biology and zoology. NU also provides services in business management, chemical engineering, civil engineering, classics and ancient history; computing science, history, journalism, law and others. The university offers research programs in humanities and social sciences; medical sciences, science, agriculture and engineering areas. It also provides accommodation to its students. The university has its operations ......
$250

Endo Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Endo Pharmaceuticals Inc (Endo Pharmaceuticals), a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and over-the-counter medications. Its products include testosterone undecanoate injection CIII, buprenorphine buccal film CIII, alprostadil for injection, testosterone gel CIII, frovatriptan succinate tablets, lidocaine patch, cyanocobalamin, and others. Endo Pharmaceuticals provides USP nasal spray, testosterone nasal gel Clll, oxymorphone hydrochloride injection CII, and oxymorphone hydrochloride tablets CII, among others. It offers its products for the treatment of various therapeutic areas such as pain management, men's health, urology, orthopedics and......
$250

Embera NeuroTherapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Embera NeuroTherapeutics Inc (Embera) is a contract research company that discovers and develops new treatments. The company's product includes EMB-001, a drug combination for the stress response system and specific brain functions that results in craving and improvement associated with these disorders. It offers preclinical studies, clinical research and clinical trial services. Embera provides products and therapeutics for smoking cessation, cocaine dependence and other addictions. The company operates through other health sciences center to support a cocaine dependence development program. It also provides clinical development and research services. The company operates through its offices in Sudbury and Shreveport. Embera is headquartered in Shreveport, Louisiana, the US. ......
$250

EndoGastric Solutions Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company's products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesophageal valve. EGS' products are also used to perform transoral incisionless fundoplication. The company's serosa-fuse fasteners are deployed using EsophyX devices to facilitate esophagogastric tissue plications. Its products provide solutions for hospital stay, reduced patient discomfort, faster patient recovery and patient satisfaction programs. The company develops natural orifice surgical products and procedures to treat gastrointestinal diseases. EGS is headquartered in Redmond, Washington......
$250

Courtagen Life Sciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Courtagen Life Sciences Inc (Courtagen) is a medical device company that provides neurological treatment solutions. The company's products include neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. Courtagen's products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. The company serves patients and physicians. It operates in the US and Bermuda. Courtagen is headqua......
$250

Cyxone AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company's lead product include T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral administration. It also offers cyclotides, a new class of highly specific low toxicity drugs that can be used for several immune-related diseases and cancers. Cyxone collaborates with other medical universities for the development of cyclotide. The company also conducts preclinical studies and phase I clinical trials. It operates across Austria and Germany. Cyxone is headquartered in Malmo, Sweden. Cyxone AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides ......
$250

Polyplus-Transfection SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Polyplus-Transfection SA (Polyplus) is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. The company develops its RNA interference such as STICKY SIRNA and SIRNAPLUS for invivo research. Polyplus also develops transfection reagents which include JetPRIME, JetPEI, PEIpro, INTERFERin, PULSin and ZNA among others. Polyplus also provides reagents for preclinical and clinical trials. The company's products find application in gene expression, RNA interference, protein production, in vivo delivery, virus production, molecular biology and diagnostics and protein delivery. It markets its wide range of transfection reagents through a global distributor network. Polyplus is headquarte......
$250

G1 Therapeutics Inc (GTHX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc is a healthcare company that develops novel, and small molecule therapies. The company pipeline products include CDK4/6, trilaciclib G1T28 a drug candidate; G1T38 a potential best compound, and G1T48. It undertakes discovery and development of innovative small molecules for utilization in cancer therapy and biodefense applications. G1 Therapeutics discovers new small molecule-based methods that prevent the hematological side effects of cancer chemotherapy and exposure to ionizing radiation. The company also develops small molecules to target specific proteins associated with cell proliferation and growth. It operates through its laboratory located Research Triangle Park. G1 Therapeutics is headquartered in R......
$250